Cost-utility and biological underpinnings of Mindfulness-Based Stress Reduction (MBSR) versus a psychoeducational programme (FibroQoL) for fibromyalgia: a 12-month randomised controlled trial (EUDAIMON study)

[1]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[2]  S. Schilling,et al.  Multidimensional Inventory of Subjective Cognitive Impairment , 2016 .

[3]  G. Littlejohn.  Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome , 2015, Nature Reviews Rheumatology.

[4]  Ather Ali,et al.  Fibromyalgia Impact and Mindfulness Characteristics in 4986 People with Fibromyalgia. , 2015, Explore.

[5]  David A. Williams,et al.  Development and initial validation of a brief self-report measure of cognitive dysfunction in fibromyalgia. , 2015, The journal of pain : official journal of the American Pain Society.

[6]  L. McCracken,et al.  Patients' impression of change following treatment for chronic pain: global, specific, a single dimension, or many? , 2015, The journal of pain : official journal of the American Pain Society.

[7]  N. Scott,et al.  Does mindfulness improve outcomes in patients with chronic pain? Systematic review and meta-analysis. , 2015, The British journal of general practice : the journal of the Royal College of General Practitioners.

[8]  Jan J. V. Busschbach,et al.  Standardised Mindfulness-Based Interventions in Healthcare: An Overview of Systematic Reviews and Meta-Analyses of RCTs , 2015, PloS one.

[9]  J. Luciano,et al.  Bifactor analysis and construct validity of the five facet mindfulness questionnaire (FFMQ) in non-clinical Spanish samples , 2015, Front. Psychol..

[10]  Kate Cavanagh,et al.  How do mindfulness-based cognitive therapy and mindfulness-based stress reduction improve mental health and wellbeing? A systematic review and meta-analysis of mediation studies. , 2015, Clinical psychology review.

[11]  Britta K. Hölzel,et al.  The neuroscience of mindfulness meditation , 2015, Nature Reviews Neuroscience.

[12]  R. Willke,et al.  Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[13]  Ausiàs Cebolla,et al.  The implementation of mindfulness in healthcare systems: a theoretical analysis. , 2015, General hospital psychiatry.

[14]  L. Ost.  The efficacy of Acceptance and Commitment Therapy: an updated systematic review and meta-analysis. , 2014, Behaviour research and therapy.

[15]  Y. Shoenfeld,et al.  Fibromyalgia and cytokines. , 2014, Immunology letters.

[16]  J. Luciano,et al.  Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial , 2014, Arthritis Research & Therapy.

[17]  I. Russell,et al.  More ubiquitous effects from non‐pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: A meta‐analysis examining six core symptoms , 2014, European journal of pain.

[18]  D. Moher,et al.  SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) , 2014 .

[19]  Laura Blanco-Hinojo,et al.  The contribution of sensory system functional connectivity reduction to clinical pain in fibromyalgia , 2014, PAIN®.

[20]  B. Cagnie,et al.  Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRI. , 2014, Seminars in arthritis and rheumatism.

[21]  W. Marchand.  Neural mechanisms of mindfulness and meditation: Evidence from neuroimaging studies. , 2014, World journal of radiology.

[22]  Michael R. Irwin,et al.  The Effects of Mind-Body Therapies on the Immune System: Meta-Analysis , 2014, PloS one.

[23]  A. Chur-Hansen,et al.  The Effectiveness of Mindfulness-based Programs on Physical Symptoms and Psychological Distress in Patients with Fibromyalgia: A Systematic Review , 2014 .

[24]  J. Luciano,et al.  Bifactor analysis and construct validity of the HADS: a cross-sectional and longitudinal study in fibromyalgia patients. , 2014, Psychological assessment.

[25]  Matthew L. Dixon,et al.  Is meditation associated with altered brain structure? A systematic review and meta-analysis of morphometric neuroimaging in meditation practitioners , 2014, Neuroscience & Biobehavioral Reviews.

[26]  Y. López-del-Hoyo,et al.  Effectiveness of group acceptance and commitment therapy for fibromyalgia: A 6-month randomized controlled trial (EFFIGACT study) , 2014, PAIN®.

[27]  V. Menzies,et al.  Unique Cytokine Signature in the Plasma of Patients with Fibromyalgia , 2014, Journal of immunology research.

[28]  A. Lutz,et al.  Rapid changes in histone deacetylases and inflammatory gene expression in expert meditators , 2014, Psychoneuroendocrinology.

[29]  Marcelo Marcos Piva Demarzo,et al.  Validation of the Spanish versions of the long (26 items) and short (12 items) forms of the Self-Compassion Scale (SCS) , 2014, Health and Quality of Life Outcomes.

[30]  J. Langhorst,et al.  A systematic review and meta-analysis of mindfulness-based stress reduction for the fibromyalgia syndrome. , 2013, Journal of psychosomatic research.

[31]  J. Luciano,et al.  Dimensionality, Reliability, and Validity of the Revised Fibromyalgia Impact Questionnaire in Two Spanish Samples , 2013, Arthritis care & research.

[32]  Kerry L. Schofield,et al.  Mindfulness-Based Therapies in the Treatment of Somatization Disorders: A Systematic Review and Meta-Analysis , 2013, PloS one.

[33]  J. Luciano,et al.  Cost-Utility of a Psychoeducational Intervention in Fibromyalgia Patients Compared With Usual Care: An Economic Evaluation Alongside a 12-Month Randomized Controlled Trial , 2013, The Clinical journal of pain.

[34]  K. Jones.  A Mindful Future for Fibromyalgia?: a Comment on Davis and Zautra , 2013, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[35]  David Moher,et al.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement , 2013, Journal of medical economics.

[36]  J. Luciano,et al.  Validation of a Spanish version of the psychological inflexibility in pain scale (PIPS) and an evaluation of its relation with acceptance of pain and mindfulness in sample of persons with fibromyalgia , 2013, Health and Quality of Life Outcomes.

[37]  Andrew H. Miller,et al.  CYTOKINE TARGETS IN THE BRAIN: IMPACT ON NEUROTRANSMITTERS AND NEUROCIRCUITS , 2013, Depression and anxiety.

[38]  David Moher,et al.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement , 2013, International Journal of Technology Assessment in Health Care.

[39]  M. Drummond,et al.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement , 2013, BMJ.

[40]  M. Irwin,et al.  Yogic meditation reverses NF-κB and IRF-related transcriptome dynamics in leukocytes of family dementia caregivers in a randomized controlled trial , 2013, Psychoneuroendocrinology.

[41]  D. Rennie,et al.  SPIRIT 2013 statement: defining standard protocol items for clinical trials. , 2013, Annals of internal medicine.

[42]  A. Serretti,et al.  Mindfulness: top-down or bottom-up emotion regulation strategy? , 2013, Clinical psychology review.

[43]  J. Toldi,et al.  Kynurenines in the CNS: recent advances and new questions , 2012, Nature Reviews Drug Discovery.

[44]  J. Kleijnen,et al.  Chronic Diseases in the European Union: The Prevalence and Health Cost Implications of Chronic Pain , 2012, Journal of pain & palliative care pharmacotherapy.

[45]  Steven C. R. Williams,et al.  Alterations in resting-state regional cerebral blood flow demonstrate ongoing pain in osteoarthritis: An arterial spin-labeled magnetic resonance imaging study. , 2012, Arthritis and rheumatism.

[46]  Matthew D. Lieberman,et al.  Mindfulness-Based Stress Reduction training reduces loneliness and pro-inflammatory gene expression in older adults: A small randomized controlled trial , 2012, Brain, Behavior, and Immunity.

[47]  D. Ffytche,et al.  The Antisocial Brain: Psychopathy Matters: A Structural MRI Investigation of Antisocial Male Violent Offenders , 2012 .

[48]  Shuxing Wang,et al.  Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. , 2012, The Journal of clinical investigation.

[49]  Richard E. Harris,et al.  Decreased intrinsic brain connectivity is associated with reduced clinical pain in fibromyalgia. , 2012, Arthritis and rheumatism.

[50]  F. Wolfe,et al.  Validation of the Fibromyalgia Survey Questionnaire within a Cross-Sectional Survey , 2012, PloS one.

[51]  J. Lampa,et al.  Evidence of central inflammation in fibromyalgia — Increased cerebrospinal fluid interleukin-8 levels , 2012, Journal of Neuroimmunology.

[52]  Peter Fransson,et al.  Patients with fibromyalgia display less functional connectivity in the brain’s pain inhibitory network , 2012, Molecular pain.

[53]  F. Zelaya,et al.  Pulsed arterial spin labeling perfusion imaging at 3 T: estimating the number of subjects required in common designs of clinical trials. , 2011, Magnetic resonance imaging.

[54]  J. Gray,et al.  Meditation experience is associated with differences in default mode network activity and connectivity , 2011, Proceedings of the National Academy of Sciences.

[55]  C. Sommer,et al.  Systematic review with meta-analysis: cytokines in fibromyalgia syndrome , 2011, BMC musculoskeletal disorders.

[56]  C. Boomershine.  A Comprehensive Evaluation of Standardized Assessment Tools in the Diagnosis of Fibromyalgia and in the Assessment of Fibromyalgia Severity , 2011, Pain research and treatment.

[57]  F. Wolfe,et al.  Fibromyalgia diagnosis and diagnostic criteria , 2011, Annals of medicine.

[58]  D. Goldenberg,et al.  The comparative burden of mild, moderate and severe Fibromyalgia: results from a cross-sectional survey in the United States , 2011, Health and quality of life outcomes.

[59]  M. Bloch,et al.  The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis , 2011, Neuropsychopharmacology.

[60]  F. Raes,et al.  Construction and factorial validation of a short form of the Self-Compassion Scale. , 2011, Clinical psychology & psychotherapy.

[61]  G. Bonsel,et al.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) , 2011, Quality of Life Research.

[62]  Robert A. Kraft,et al.  Brain Mechanisms Supporting the Modulation of Pain by Mindfulness Meditation , 2011, The Journal of Neuroscience.

[63]  M. Power,et al.  Exposing the evidence gap for complementary and alternative medicine to be integrated into science-based medicine , 2011, Journal of the Royal Society of Medicine.

[64]  Ernst T. Bohlmeijer,et al.  Acceptance-based interventions for the treatment of chronic pain: A systematic review and meta-analysis , 2011, PAIN®.

[65]  Britta K. Hölzel,et al.  Mindfulness practice leads to increases in regional brain gray matter density , 2011, Psychiatry Research: Neuroimaging.

[66]  Jun Soo Kwon,et al.  Increased default mode network connectivity associated with meditation , 2011, Neuroscience Letters.

[67]  G. Feixas,et al.  Cognitive Factors in Fibromyalgia: The Role of Self-Concept and Identity Related Conflicts , 2010, Journal of constructivist psychology.

[68]  Kyungmo Park,et al.  Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity. , 2010, Arthritis and rheumatism.

[69]  J. Branco,et al.  Prevalence of fibromyalgia: a survey in five European countries. , 2010, Seminars in arthritis and rheumatism.

[70]  D. Moher,et al.  CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials , 2010, PLoS medicine.

[71]  R. Bennett,et al.  The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties , 2009, Arthritis research & therapy.

[72]  C. Sorg,et al.  Patients With Pain Disorder Show Gray-Matter Loss in Pain-Processing Structures: A Voxel-Based Morphometric Study , 2009, Psychosomatic medicine.

[73]  R. Durazo-Arvizu,et al.  Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer , 2008, Brain, Behavior, and Immunity.

[74]  F. Bond,et al.  Avoidance and cognitive fusion – Central components in pain related disability? Development and preliminary validation of the Psychological Inflexibility in Pain Scale (PIPS) , 2008, European journal of pain.

[75]  Gregory T. Smith,et al.  Construct Validity of the Five Facet Mindfulness Questionnaire in Meditating and Nonmeditating Samples , 2008, Assessment.

[76]  P. Manganelli,et al.  Fibromyalgia and psychiatric disorders. , 2007, Acta bio-medica : Atenei Parmensis.

[77]  R. Dantzer.  Cytokine, sickness behavior, and depression. , 2006, Neurologic clinics.

[78]  E. Remor,et al.  Psychometric Properties of a European Spanish Version of the Perceived Stress Scale (PSS) , 2006, The Spanish Journal of Psychology.

[79]  P. Grossman,et al.  Mindfulness-based stress reduction and health benefits. A meta-analysis. , 2004, Journal of psychosomatic research.

[80]  J. Krystal,et al.  Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. , 2004, Archives of general psychiatry.

[81]  Paul J. Laurienti,et al.  An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets , 2003, NeuroImage.

[82]  高松 潔,et al.  婦人科入院患者におけるメンタルヘルス : HADS(Hospital Anxiety and Depression Scale)を用いた検討 , 2001 .

[83]  G. Devilly,et al.  Psychometric properties of the credibility/expectancy questionnaire. , 2000, Journal of behavior therapy and experimental psychiatry.

[84]  Antonio Lobo,et al.  Revalidación y normalización del Mini-Examen Cognoscitivo (primera versión en castellano del Mini-Mental Status Examination) en la población general geriátrica , 1999 .

[85]  D L Sackett,et al.  An assessment of clinically useful measures of the consequences of treatment. , 1988, The New England journal of medicine.

[86]  Huston Gj,et al.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[87]  J. Kabat-Zinn,et al.  An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: theoretical considerations and preliminary results. , 1982, General hospital psychiatry.

[88]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[89]  M. Erickson.  Naturalistic Techniques of Hypnosis , 1958 .

[90]  F. Wolfe,et al.  Convergence between the 1990 and 2010 ACR diagnostic criteria and validation of the Spanish version of the Fibromyalgia Survey Questionnaire (FSQ) , 2014, Rheumatology International.

[91]  B. Clotet,et al.  Effectiveness of Mindfulness-Based Cognitive Therapy on the Quality of Life, Emotional Status, and CD4 Cell Count of Patients Aging with HIV Infection , 2013, AIDS and Behavior.

[92]  D. Ffytche,et al.  The antisocial brain: psychopathy matters. , 2012, Archives of general psychiatry.

[93]  Javier García Campayo,et al.  [Validation of the Spanish version of the Pain Catastrophizing Scale in fibromyalgia]. , 2008, Medicina clinica.

[94]  S. Kachur.  Understanding and Treating Fear of Pain , 2008 .

[95]  A. Lobo,et al.  [Revalidation and standardization of the cognition mini-exam (first Spanish version of the Mini-Mental Status Examination) in the general geriatric population]. , 1999, Medicina clinica.

[96]  L. Healey.  On fibromyalgia. , 1996, Bulletin on the rheumatic diseases.

[97]  Scott R. Bishop,et al.  The Pain Catastrophizing Scale: Development and validation. , 1995 .

[98]  Martin Knapp,et al.  Costing psychiatric interventions. , 1992 .

[99]  Sheldon Cohen.  Perceived stress in a probability sample of the United States , 1988 .